HomePfizer

Pfizer

Should Investors Consider Buying Pfizer Stock After a 32% Decline in a Year?

Should Investors Consider Buying Pfizer Stock After a 32% Decline in a Year?

April 5, 2024

Pfizer to Trim Ownership Stake in Haleon from 32% to 24%

Pfizer to Trim Ownership Stake in Haleon from 32% to 24%

March 19, 2024

Pfizer’s Adcetris Achieves Survival Goal in Lymphoma Study

Pfizer’s Adcetris Achieves Survival Goal in Lymphoma Study

March 13, 2024

Pfizer Reports Strong Q4 Earnings, but Faces Revenue Dip Due to COVID Sales Slowdown

Pfizer Reports Strong Q4 Earnings, but Faces Revenue Dip Due to COVID Sales Slowdown

January 30, 2024

Pfizer Stock Outlook: Navigating the Future

Pfizer Stock Outlook: Navigating the Future

January 2, 2024

Pfizer Faces Revenue Decline Due to COVID-19 Product Sales Drop

Pfizer Faces Revenue Decline Due to COVID-19 Product Sales Drop

October 31, 2023

Pfizer Set to Announce Q2 Earnings: Anticipated Outlook

Pfizer Set to Announce Q2 Earnings: Anticipated Outlook

July 25, 2023

Pfizer Will Raise $31B in Debt to Fund the Seagen Acquisition

Pfizer Will Raise $31B in Debt to Fund the Seagen Acquisition

May 17, 2023

Pfizer Stock Has Likely Already Bottomed

Pfizer Stock Has Likely Already Bottomed

February 14, 2023